iStent inject Trabecular Micro-Bypass System (Model G2-M-IS)

Intraocular Pressure Lowering Implant

FDA Premarket Approval P170043 S002

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval of the revised protocol for the post-approval study (pas) protocol.

• Device: iStent inject Trabecular Micro-Bypass System (Model G2-M-IS)
• Classification Name: Intraocular Pressure Lowering Implant
• Generic Name: Intraocular Pressure Lowering Implant
• Applicant: Glaukos Corporation
• Date Received: 2018-07-23
• Decision Date: 2019-04-16
• PMA: P170043
• Supplement: S002
• Product Code: OGO
• Advisory Committee: Ophthalmic
• Supplement Type: Normal 180 Day Track No User Fee
• Supplement Reason: Postapproval Study Protocol - Ode/oir
• Expedited Review: No
• Combination Product: No
• Applicant Address: Glaukos Corporation 229 Avenida Fabricante san Clemente, CA 92672

Supplemental Filings

Supplement Number	Date	Supplement Type
P170043		Original Filing
S014	2022-05-31	Normal 180 Day Track
S013
S012	2022-02-04	30-day Notice
S011
S010	2021-06-15	Normal 180 Day Track
S009	2021-03-25	135 Review Track For 30-day Notice
S008	2020-12-07	Normal 180 Day Track No User Fee
S007	2020-03-03	Normal 180 Day Track No User Fee
S006	2020-03-03	Normal 180 Day Track No User Fee
S005
S004	2019-05-02	30-day Notice
S003
S002	2018-07-23	Normal 180 Day Track No User Fee
S001	2018-07-23	Normal 180 Day Track No User Fee

NIH GUDID Devices

Device ID	PMA	Supp
00853704002203	P170043	000
00853704002319	P170043	005